An interventional study of Arthroplasty CMC-1 in Osteoarthritis of the CMC-1 Joint, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2025-09-23.
Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 78 studies in Osteoarthritis with a site in Sweden — 12 open to participants now, 25 under way, none of them phase 3. Osteoarthritis · Sweden.
Among the 78 studies in Osteoarthritis with a site in Sweden, this one is the 30th largest by planned enrollment of the 57 interventional ones that give a count, is one of 4 that started in 2025, is one of 41 with no phase, reaches primary completion later than 24 of the 24 other live ones, and was the 75th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →12 of the 78 studies in Osteoarthritis with a site in Sweden are open now. Recruiting first, the newest first:
Uppsala University · Sites in Sweden
Ages 18–75
Sahlgrenska University Hospital · Sites in Sweden
Ages 18+ · Healthy volunteers
Vastra Gotaland Region · Sites in Sweden
Ages 30+
Uppsala University · Sites in Sweden
Ages 18–100
University Hospital, Basel, Switzerland · Sites in Sweden, Austria, Croatia and 5 more countries
Ages 18–70
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
78 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 7 · Phase 4 5
First in 1997; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 98 across the 57 interventional studies, 500 across the 21 observational. Of the 42 that completed or were terminated, 12 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 78 have an industry lead sponsor. The 10 most frequent:
Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.
Karolinska Institutet has 8 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
3 of the studies in Osteoarthritis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04210687Karolinska InstitutetTrapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis | 2026-12-01 |
| NCT05584410Vastra Gotaland RegionDigitalization of Osteoarthritis Care | 2026-12-31 |
| NCT07383740Vastra Gotaland RegionTest-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 78 studies in Osteoarthritis with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Osteoarthritis in the base of the thumb is one of the most common forms of hand arthritis. It usually appears in middle age, particularly in women, and can cause significant pain and loss of function. Early treatment often includes splints, painkillers, joint protection techniques, or steroid injections. If these measures are not enough, surgery is considered.
The current standard operation in Sweden is trapeziectomy-removing the trapezium. This usually gives good pain relief at rest, but many patients continue to experience pain when loading the hand and reduced grip strength. Another surgical option is trapeziometacarpal limited excision (TLE), where only part of the bone is removed to keep the thumb slightly longer, which may improve strength. Both procedures are non-implant surgeries.
A newer alternative is total joint arthroplasty (TJA), where the joint is replaced with a prosthesis. Early studies suggest that this may allow for quicker recovery and possibly better strength compared to trapeziectomy. However, it is more expensive and carries higher risks, such as implant loosening or dislocation. So far, research has not proven that it offers better long-term results.
The TRACE study (A single arm trial of Thumb base Replacement Arthroplasty for osteoarthritis Compared to External controls) is designed to help answer this question. Instead of randomizing patients, this study will follow a group of people receiving thumb joint replacement and compare them to an existing group of patients who already took part in a randomized trial of trapeziectomy and TLE. This design allows the researchers to study results more quickly and with fewer resources, while still ensuring meaningful comparisons.
The main research question of this study is whether joint replacement gives better pain relief when loading the thumb 10 years after surgery compared to traditional non-implant operations in patients with painful thumb base osteoarthritis. Secondary questions include whether joint replacement improves patient-reported outcomes, hand function, and strength, and whether it leads to more or fewer complications at 1, 3, and 5 years after surgery.
90 patients will be included in the replacement group, using a dual mobility prosthesis. Their outcomes will be compared with 90 patients from the earlier trial (45 trapeziectomy and 45 limited trapeziometacarpal joint resection - TLE). The study will track pain, daily hand function, strength, range of motion, and complications such as infection or the need for further surgery. Data will be collected regularly for up to 10 years.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The inclusion criteria are identical to those of the control population.
Exclusion Criteria:
The previously described exclusion criteria are identical to those of the control population. In addition patients with severe deformation of the trapezium, to the extent that it is not possible to place a prosthetic cup, will be excluded.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Arthroplasty CMC-1
Procedure: Arthroplasty CMC-1
Touch Touch® dual-mobility Arthroplasty CMC-1 joint (Kerimed). Dorsal approach. Conical cup. Soft dressing 3 weeks. Loading allowed after 2 months.
Pain on load in the thumb 10 years postoperatively.
Pain on load is rated with a self-administered 11-point numerical rating scale (NRS) 0-100 from the HQ-7 questionnaire. Higher score means more pain. The participants are asked to rate the pain the previous week.
Time frame: 10 years postoperatively
Pain on load in the thumb 3 and 6 months, 1, 3, and 5 years postoperatively.
Pain on load is rated with a self-administered 11-point numerical rating scale (NRS) 0-100 from the HQ-7 questionnaire. Higher score means mote pain. The participants are asked to rate the pain the previous week.
Time frame: from enrollment to 5 years postoperatively
HQ-8 score 3 and 6 months, 1,3, 5 and 10 years postoperatively
Self-administered 11-point numerical rating scale (NRS) 0-100 symptoms questionnaire. Symptoms inlcude pain at rest, pain on motion, stiffness, weakness. Higher score means more symptoms. HQ-8 is the symptom-rating scale in the Swedish Hand surgical quality registry (HAKIR).
Time frame: From enrollment to 10 years postoperatively
Patient-rated Wrist and Hand (PRWHE) score 3 and 6 months, 1,3, 5 and 10 years postoperatively
Patient-rated Wrist and Hand (PRWHE). Scale 0-100, higher score means more pain and disability,
Time frame: From enrollment to 10 years postoperatively
Distability of the Arm, Hand and Shoulder (DASH) score 3 and 6 months, 1,3, 5 and 10 years postoperatively
Distability of the Arm, Hand and Shoulder (DASH) score range from 0 to 100, higher score means more disability,
Time frame: From enrollment to 10 years postoperatively.
Thumb range of motion 3 and 6 months, 1,3, 5 and 10 years postoperatively
Palmar and radial abduction (degrees) of the first metacarpal measured with a goniometer
Time frame: From enrollment to 10 years postoperatively
Adverse events
Number of particiant with a diagnosed infection, complex regional pain syndrome (CRPS), superficial radial sensory nerve injury or revision surgery required.
Time frame: From enrollment to 10 years postoperatively.
Thumb strength 1,3, 5 and 10 years postoperatively
Key pinch and three-finger pinch measured with a pinch gauge (kilograms).
Time frame: From enrollment to 10 years postoperatively
Hand strength 1,3, 5 and 10 years postoperatively
Full hand grip strength measured with Jamar (kilograms).
Time frame: From enrollment to 10 years postoperatively
Plan to share: Yes — A description of the variables collected throughout the trial and used in the results publication will be provided when the study is finished.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: Beginning 3 months and ending 6 years after the publication of the final (10 years) results.
Access criteria: Data will be shared for systematic reviews/metananalyses. The statistical methods for those analyses need not to be approved by an independent review. A proposal that describes planned analyses must be submitted by e-mail to the corresponding author who will review requests for IPD sharing.
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2038, 160 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 160 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.